Development of a 3-month implantable depot pellet of Naltrexone for the treatment of Opioid Use Disorder.

Information

• Research Project
• 10456354

• ApplicationId

  10456354

• Core Project Number

  UH3DA047925

• Full Project Number

  4UH3DA047925-03

• Serial Number

  047925

• FOA Number

  RFA-DA-19-002

• Sub Project Id

• Project Start Date

  2/1/2019 - 5 years ago

• Project End Date

  8/31/2023 - a year ago

• Program Officer Name

  KLINE, RICHARD

• Budget Start Date

  9/1/2021 - 3 years ago

• Budget End Date

  8/31/2023 - a year ago

• Fiscal Year

  2021

• Support Year

  03

• Suffix

• Award Notice Date

  8/27/2021 - 3 years ago

Organizations

• BIOCORRX, INC

IC Name

• Activity

  UH3

• Administering IC

  DA

• Application Type

  4

• Direct Cost Amount

  2951596

• Indirect Cost Amount

  501771

• Total Cost

  3453367

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  279

• Ed Inst. Type

• Funding ICs

  NIDA:3453367\

• Funding Mechanism

  Non-SBIR/STTR RPGs

• Study Section

  ZDA1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  BIOCORRX, INC.

• Organization Department

• Organization DUNS

  079276398

• Organization City

  ANAHEIM

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  92806

• Organization District

  UNITED STATES